vs

Side-by-side financial comparison of Cibus, Inc. (CBUS) and OneMedNet Corp (ONMD). Click either name above to swap in a different company.

Cibus, Inc. is the larger business by last-quarter revenue ($1.1M vs $890.0K, roughly 1.2× OneMedNet Corp). OneMedNet Corp runs the higher net margin — -352.8% vs -2959.9%, a 2607.1% gap on every dollar of revenue. On growth, OneMedNet Corp posted the faster year-over-year revenue change (3323.1% vs -12.8%). OneMedNet Corp produced more free cash flow last quarter ($-1.7M vs $-13.5M). Over the past eight quarters, OneMedNet Corp's revenue compounded faster (66.3% CAGR vs 39.3%).

Cibus, Inc. is a leading agricultural biotechnology firm specializing in precision gene editing technologies to develop improved, sustainable crop traits. Its solutions include herbicide tolerance, disease and pest resistance, and enhanced yield characteristics for major row crops, serving global agricultural markets, seed producers, and farming communities to reduce environmental impact and boost operational efficiency.

OneMedNet Corp is a U.S.-headquartered healthcare tech firm offering secure cloud-based data sharing and workflow solutions for medical imaging and patient health information. It serves healthcare providers, insurance payers, and life sciences groups, with its core operating market centered in North America.

CBUS vs ONMD — Head-to-Head

Bigger by revenue
CBUS
CBUS
1.2× larger
CBUS
$1.1M
$890.0K
ONMD
Growing faster (revenue YoY)
ONMD
ONMD
+3335.9% gap
ONMD
3323.1%
-12.8%
CBUS
Higher net margin
ONMD
ONMD
2607.1% more per $
ONMD
-352.8%
-2959.9%
CBUS
More free cash flow
ONMD
ONMD
$11.8M more FCF
ONMD
$-1.7M
$-13.5M
CBUS
Faster 2-yr revenue CAGR
ONMD
ONMD
Annualised
ONMD
66.3%
39.3%
CBUS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBUS
CBUS
ONMD
ONMD
Revenue
$1.1M
$890.0K
Net Profit
$-31.3M
$-3.1M
Gross Margin
20.7%
Operating Margin
-2135.7%
-353.4%
Net Margin
-2959.9%
-352.8%
Revenue YoY
-12.8%
3323.1%
Net Profit YoY
-35.4%
-32.3%
EPS (diluted)
$-0.39
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBUS
CBUS
ONMD
ONMD
Q4 25
$1.1M
$890.0K
Q3 25
$615.0K
$177.0K
Q2 25
$933.0K
$155.0K
Q1 25
$1.0M
$137.0K
Q4 24
$1.2M
Q3 24
$1.7M
$142.0K
Q2 24
$838.0K
$227.0K
Q1 24
$545.0K
$248.0K
Net Profit
CBUS
CBUS
ONMD
ONMD
Q4 25
$-31.3M
$-3.1M
Q3 25
$-23.5M
$-741.0K
Q2 25
$-25.4M
$3.0M
Q1 25
$-46.9M
$-1.9M
Q4 24
$-23.1M
Q3 24
$-180.0M
$-2.1M
Q2 24
$-24.9M
$-3.6M
Q1 24
$-23.4M
$-2.1M
Gross Margin
CBUS
CBUS
ONMD
ONMD
Q4 25
20.7%
Q3 25
-125.4%
Q2 25
-155.5%
Q1 25
-163.5%
Q4 24
Q3 24
-59.2%
Q2 24
-44.9%
Q1 24
-27.8%
Operating Margin
CBUS
CBUS
ONMD
ONMD
Q4 25
-2135.7%
-353.4%
Q3 25
-2510.2%
-1262.7%
Q2 25
-1923.5%
-1331.0%
Q1 25
-4020.4%
-1623.4%
Q4 24
-1487.1%
Q3 24
-12023.8%
-1645.1%
Q2 24
-2563.5%
-1081.1%
Q1 24
-3385.9%
-847.2%
Net Margin
CBUS
CBUS
ONMD
ONMD
Q4 25
-2959.9%
-352.8%
Q3 25
-3827.8%
-418.6%
Q2 25
-2719.4%
1923.9%
Q1 25
-4534.4%
-1388.3%
Q4 24
-1906.1%
Q3 24
-10795.9%
-1449.3%
Q2 24
-2969.3%
-1581.1%
Q1 24
-4300.0%
-850.4%
EPS (diluted)
CBUS
CBUS
ONMD
ONMD
Q4 25
$-0.39
$-0.06
Q3 25
$-0.44
$-0.01
Q2 25
$-0.61
$0.07
Q1 25
$-1.34
$-0.06
Q4 24
$-0.94
Q3 24
$-7.63
$-0.07
Q2 24
$-1.14
$-0.14
Q1 24
$-1.12
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBUS
CBUS
ONMD
ONMD
Cash + ST InvestmentsLiquidity on hand
$9.9M
$585.0K
Total DebtLower is stronger
$528.0K
$220.0K
Stockholders' EquityBook value
$21.8M
$-3.0M
Total Assets
$305.0M
$2.2M
Debt / EquityLower = less leverage
0.02×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBUS
CBUS
ONMD
ONMD
Q4 25
$9.9M
$585.0K
Q3 25
$23.9M
$149.0K
Q2 25
$36.5M
$122.0K
Q1 25
$23.6M
$144.0K
Q4 24
$14.4M
Q3 24
$28.8M
$1.9M
Q2 24
$30.0M
$407.0K
Q1 24
$24.5M
$174.0K
Total Debt
CBUS
CBUS
ONMD
ONMD
Q4 25
$528.0K
$220.0K
Q3 25
Q2 25
Q1 25
$2.3M
Q4 24
$662.0K
Q3 24
$2.3M
Q2 24
$2.4M
Q1 24
Stockholders' Equity
CBUS
CBUS
ONMD
ONMD
Q4 25
$21.8M
$-3.0M
Q3 25
$50.4M
$-3.9M
Q2 25
$72.1M
$-3.8M
Q1 25
$70.3M
$-16.6M
Q4 24
$92.2M
Q3 24
$108.1M
$-14.3M
Q2 24
$270.5M
$-19.2M
Q1 24
$278.2M
$-15.7M
Total Assets
CBUS
CBUS
ONMD
ONMD
Q4 25
$305.0M
$2.2M
Q3 25
$330.2M
$1.5M
Q2 25
$346.2M
$2.3M
Q1 25
$335.0M
$1.7M
Q4 24
$350.1M
Q3 24
$367.9M
$4.4M
Q2 24
$553.4M
$1.0M
Q1 24
$533.0M
$750.0K
Debt / Equity
CBUS
CBUS
ONMD
ONMD
Q4 25
0.02×
Q3 25
Q2 25
Q1 25
Q4 24
0.01×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBUS
CBUS
ONMD
ONMD
Operating Cash FlowLast quarter
$-13.4M
$-1.7M
Free Cash FlowOCF − Capex
$-13.5M
$-1.7M
FCF MarginFCF / Revenue
-1277.8%
-193.0%
Capex IntensityCapex / Revenue
8.1%
0.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-51.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBUS
CBUS
ONMD
ONMD
Q4 25
$-13.4M
$-1.7M
Q3 25
$-11.7M
$-1.6M
Q2 25
$-13.6M
$-2.3M
Q1 25
$-11.8M
$-1.9M
Q4 24
$-14.0M
Q3 24
$-13.5M
$-1.9M
Q2 24
$-17.0M
$-1.5M
Q1 24
$-13.5M
$-1.5M
Free Cash Flow
CBUS
CBUS
ONMD
ONMD
Q4 25
$-13.5M
$-1.7M
Q3 25
$-11.8M
Q2 25
$-13.7M
$-2.3M
Q1 25
$-12.1M
$-2.0M
Q4 24
$-14.1M
Q3 24
$-13.9M
$-1.9M
Q2 24
$-17.2M
$-1.5M
Q1 24
$-13.7M
$-1.6M
FCF Margin
CBUS
CBUS
ONMD
ONMD
Q4 25
-1277.8%
-193.0%
Q3 25
-1926.5%
Q2 25
-1468.1%
-1475.5%
Q1 25
-1172.0%
-1425.5%
Q4 24
-1159.3%
Q3 24
-832.3%
-1346.5%
Q2 24
-2054.5%
-663.9%
Q1 24
-2515.2%
-626.2%
Capex Intensity
CBUS
CBUS
ONMD
ONMD
Q4 25
8.1%
0.6%
Q3 25
17.6%
0.0%
Q2 25
10.0%
1.9%
Q1 25
28.1%
3.6%
Q4 24
4.6%
Q3 24
21.3%
6.3%
Q2 24
20.2%
0.4%
Q1 24
41.8%
2.4%
Cash Conversion
CBUS
CBUS
ONMD
ONMD
Q4 25
Q3 25
Q2 25
-0.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons